HansBiomed Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for HansBiomed.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 81.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Oct 29
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Feb 29HansBiomed Corporation (KOSDAQ:042520) Shares Fly 25% But Investors Aren't Buying For Growth
Feb 29Are Dividend Investors Making A Mistake With HansBiomed Corporation (KOSDAQ:042520)?
Apr 10Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?
Mar 06HansBiomed's(KOSDAQ:042520) Share Price Is Down 63% Over The Past Three Years.
Jan 30Are HansBiomed's (KOSDAQ:042520) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Dec 08
Declining Stock and Decent Financials: Is The Market Wrong About HansBiomed Corporation (KOSDAQ:042520)?
Nov 20In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HansBiomed has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 80,639 | -9,493 | -971 | 1,559 | N/A |
| 3/31/2024 | 78,291 | -10,002 | -2,047 | 221 | N/A |
| 12/31/2023 | 78,321 | -19,694 | -4,719 | -2,803 | N/A |
| 9/30/2023 | 78,032 | -23,045 | -5,805 | -3,733 | N/A |
| 6/30/2023 | 78,561 | -9,852 | -6,519 | -4,015 | N/A |
| 3/31/2023 | 80,309 | -9,968 | -6,436 | -3,937 | N/A |
| 12/31/2022 | 76,991 | 3,152 | -6,427 | -3,548 | N/A |
| 9/30/2022 | 74,459 | 6,147 | -8,404 | -4,270 | N/A |
| 6/30/2022 | 68,200 | -10,348 | -12,602 | -7,403 | N/A |
| 3/31/2022 | 63,498 | -11,639 | -14,734 | -8,981 | N/A |
| 12/31/2021 | 58,284 | -22,373 | -18,536 | -12,802 | N/A |
| 9/30/2021 | 59,098 | -18,289 | -19,622 | -14,645 | N/A |
| 6/30/2021 | 70,297 | -25,593 | -12,475 | -6,067 | N/A |
| 3/31/2021 | 73,649 | -23,626 | -11,138 | -4,052 | N/A |
| 12/31/2020 | 80,678 | -16,686 | -5,759 | 2,051 | N/A |
| 9/30/2020 | 80,098 | -17,840 | -2,222 | 5,751 | N/A |
| 6/30/2020 | 72,293 | 5,259 | -2,574 | 3,791 | N/A |
| 3/31/2020 | 71,395 | 7,539 | -6,364 | 8,884 | N/A |
| 12/31/2019 | 69,043 | 9,867 | -8,873 | 6,536 | N/A |
| 9/30/2019 | 66,991 | 9,951 | -8,027 | 7,714 | N/A |
| 6/30/2019 | 64,768 | 5,521 | -8,854 | 5,855 | N/A |
| 3/31/2019 | 61,501 | 5,253 | -1,777 | 3,193 | N/A |
| 12/31/2018 | 56,945 | 4,508 | 2,845 | 6,605 | N/A |
| 9/30/2018 | 51,746 | 4,159 | 2,667 | 5,204 | N/A |
| 6/30/2018 | 46,866 | 6,757 | 78 | 2,147 | N/A |
| 3/31/2018 | 42,297 | 5,623 | N/A | 1,871 | N/A |
| 12/31/2017 | 39,977 | 6,150 | N/A | 4,757 | N/A |
| 9/30/2017 | 39,058 | 7,828 | N/A | 5,597 | N/A |
| 6/30/2017 | 37,269 | 6,660 | N/A | 7,747 | N/A |
| 3/31/2017 | 34,611 | 6,756 | N/A | 5,011 | N/A |
| 12/31/2016 | 32,296 | 6,373 | N/A | 1,200 | N/A |
| 9/30/2016 | 29,048 | 4,625 | N/A | 626 | N/A |
| 6/30/2016 | 27,494 | 4,911 | N/A | 2,592 | N/A |
| 3/31/2016 | 26,337 | 5,364 | N/A | 5,315 | N/A |
| 12/31/2015 | 24,118 | 4,856 | N/A | 4,505 | N/A |
| 9/30/2015 | 23,428 | 4,909 | N/A | 4,408 | N/A |
| 6/30/2015 | 23,005 | 4,271 | N/A | 4,460 | N/A |
| 3/31/2015 | 22,726 | 3,878 | N/A | 3,074 | N/A |
| 12/31/2014 | 21,451 | 3,621 | N/A | 1,928 | N/A |
| 9/30/2014 | 21,033 | 3,498 | N/A | 2,910 | N/A |
| 6/30/2014 | 21,124 | 4,116 | N/A | 2,383 | N/A |
| 3/31/2014 | 20,623 | 3,710 | N/A | 3,471 | N/A |
| 12/31/2013 | 21,099 | 4,209 | N/A | 4,669 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A042520's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A042520's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A042520's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A042520's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A042520's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A042520's Return on Equity is forecast to be high in 3 years time